44 research outputs found

    U. S. Trade in Tuna for Canning, 1987

    Get PDF
    U.S. tuna fleet activity, canned tuna processing, ex-vessel, wholesale and retail prices and imports in 1987 are described and compared to their counterparts in previous years. Industry statistics gathered from government agencies and industry contacts are presented in 14 figures and 8 tables. In 1987, U.S. tuna fisheries delivered 253,136 short tons (tons) of tuna to U.S. canneries. Domestic deliveries of albacore (white-meat) tuna were 2,836 tons, down 20 percent from 1986 levels. Domestic deliveries of tropical (light-meat) tuna (bigeye, blackfin, bluefin, skipjack, and yellowfin) were 251,000 tons, up 12 percent. Contract prices for tuna delivered by U. S. vessels to U. S. canneries increased dramatically in 1987. Depending on the size of fish in the delivery, ex-vessel prices of white-meat tuna increased as much as 27 percent, and prices of light-meat tuna increased as much as 47 percent. U. S. cannery receipts of imported and domestically caught raw frozen tuna for canning totaled 532,704 tons in 1987, up 2 percent from 1986 levels. U.S. cannery receipts of white-meat tuna were 104,197 tons, down 10 percent from 1986. Imports made up 97 percent of the total cannery supply. Total 1987 U. S. cannery receipts of raw, frozen light meat tuna were 428,507 tons, up 5 percent from 1986 levels. Imports made up 41 percent of the total cannery supply. The 1987 U.S. pack of canned tuna was 33.6 million standard cases, up 3 percent from 1986. The pack of white-meat tuna was 7.2 million standard cases, down 11 percent from 1986; the pack of light-meat tuna was 26.4 million standard cases, up 7 percent. U. S. imports of canned tuna in 1987 were 10.8 million standard cases, down 11 percent from 1986 levels, the first time in recent years that imports have declined. Per capita consumption of canned tuna in the United States was 3.5 pounds in 1987, down slightly from 1986. The retail composite price was $2.26 per pound, unchanged from 1986

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Registered Ship Notes

    Get PDF
    https://digitalmaine.com/blue_hill_documents/1179/thumbnail.jp

    The value of Pacific sardine as forage fish

    No full text
    This paper develops a simple bioeconomic model to investigate the economic and ecological issues associated with the commercial harvest of Pacific sardines relative to their value as forage for commercially, recreationally, and ecologically important predators in the California Current ecosystem. The model was used to evaluate how changes in the net per unit value of sardines, the net per unit value of sardine predators, and the transfer efficiency of predators affect the total net value of sardines, i.e. the net value of catches and the net value from sardine predation. Given recent market conditions for sardines and their commercial predators, and transfer efficiencies derived from predation data of the 1960s, it was found that the value of commercially caught predators and the efficiency by which they convert sardines to exploitable biomass were most important in determining the viability of the sardine fishery. The values assumed for predators that are not commercially caught were of no consequence under these conditions. Taking the value of sardines as forage into account does not necessarily mean an either-or situation for the fishery. As long as there is some measure of net value from the fishery and net value from predation, both benefit society at large.Pacific sardine Aquaculture Forage fish Ecosystem management Transfer efficiency California Current

    The role of research in fisheries management: The conservation of dolphins in the eastern tropical pacific and the exploitation of southern bluefin tuna in the Southern Ocean

    No full text
    This article uses two case studies to assess the role of research in policy formation and fishery management. One study focuses on measures to limit the mortality of dolphins taken when tuna are harvested in the eastern tropical Pacific. The other studies measures taken to limit harvests of Southern Bluefin Tuna. Both of these fisheries involve fugitive resources and transboundary, resources spreading across both national exclusive economic zones and the high seas. Both fisheries were initially based on open access, but public policy has led to greater exclusive use through individual transferable quotas for Southern Bluefin Tuna and dolphin mortality limits. A number of policy conclusions are drawn

    Access fees and economic benefits in the Western Pacific United States purse seine tuna fishery

    No full text
    Ideally, fees paid by distant water fishing nations for access to tuna resources in exclusive economic zones would approximate the net economic value of the tuna harvested, while leaving fishing operations profitable. This paper develops a linear programming approach to assess short-run profitability, optimum access fees and net economic benefits for US tropical tuna purse seiners operating under the South Pacific Tuna Treaty. Results suggest that there is potential for sizable short-run profits and net economic benefits after payment of an access fee equal to the imputed 'marginal value of the tuna harvested.access fees short-run profits western Pacific tuna
    corecore